ArticleScientific reports2025

Novel immune drug combination induces tumour microenvironment remodelling and reduces the dosage of anti-PD-1 antibody.

Takahiro Ozasa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.